Extrahepatic Cholangiocarcinoma clinical trials

Explore recruiting extrahepatic cholangiocarcinoma clinical trials.

Recruiting extrahepatic cholangiocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Extrahepatic Cholangiocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The CLEAN-DUCT / TRITICC-3 trial - Phase IIa, prospective, single arm, open label, non-randomized, multi-center pilot study of durvalumab (MEDI4736) + intraductal radiofrequency ablation (ID-RFA) in extrahepatic cholangiocarcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)

Norway, Italy, Poland, Spain, Belgium, Denmark +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF CYC140, AN ORAL PLK1 INHIBITOR, IN SUBJECTS WITH ADVANCED SOLID TUMORS AND LYMPHOMA

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Netherlands, France, Denmark, Germany, Norway, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Extrahepatic Cholangiocarcinoma trials by city

Extrahepatic Cholangiocarcinoma in Toronto Extrahepatic Cholangiocarcinoma in Vancouver Extrahepatic Cholangiocarcinoma in Montreal Extrahepatic Cholangiocarcinoma in Calgary Extrahepatic Cholangiocarcinoma in Edmonton Extrahepatic Cholangiocarcinoma in Ottawa Extrahepatic Cholangiocarcinoma in Winnipeg Extrahepatic Cholangiocarcinoma in Quebec City Extrahepatic Cholangiocarcinoma in Hamilton Extrahepatic Cholangiocarcinoma in Kitchener Extrahepatic Cholangiocarcinoma in London Extrahepatic Cholangiocarcinoma in Halifax Extrahepatic Cholangiocarcinoma in New York Extrahepatic Cholangiocarcinoma in Los Angeles Extrahepatic Cholangiocarcinoma in Chicago Extrahepatic Cholangiocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease